Capital Investment Advisors, LLC Novartis Ag Transaction History

Capital Investment Advisors, LLC

$4.37 Billion
Q2 2024

A detailed history of Capital Investment Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Capital Investment Advisors, LLC holds 4,638 shares of NVS stock, worth $536,384. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,638

Previous 4,516 2.7%

Holding current value

$536,384

Previous $436,000 13.07%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$92.57 - $107.37 $11,293 - $13,099	122 Added 2.7%	4,638 $493,000
Q1 2024 Apr 15, 2024	BUY	$95.27 - $108.47 $2,667 - $3,037	28 Added 0.62%	4,516 $436,000
Q4 2023 Jan 05, 2024	BUY	$92.27 - $101.54 $32,663 - $35,945	354 Added 8.56%	4,488 $453,000
Q3 2023 Oct 16, 2023	SELL	$94.73 - $105.13 $6,252 - $6,938	-66 Reduced 1.57%	4,134 $421,000
Q2 2023 Jul 11, 2023	SELL	$92.52 - $104.91 $7,864 - $8,917	-85 Reduced 1.98%	4,200 $423,000
Q1 2023 Apr 10, 2023	SELL	$80.03 - $92.81 $102,118 - $118,425	-1,276 Reduced 22.95%	4,285 $394,000
Q4 2022 Jan 05, 2023	SELL	$75.55 - $92.52 $4,381 - $5,366	-58 Reduced 1.03%	5,561 $504,000
Q3 2022 Oct 05, 2022	SELL	$74.61 - $87.26 $33,052 - $38,656	-443 Reduced 7.31%	5,619 $427,000
Q2 2022 Jul 06, 2022	BUY	$80.52 - $93.75 $22,062 - $25,687	274 Added 4.73%	6,062 $512,000
Q1 2022 Apr 13, 2022	BUY	$80.11 - $90.62 $1,361 - $1,540	17 Added 0.29%	5,788 $508,000
Q4 2021 Jan 10, 2022	SELL	$79.7 - $88.13 $25,902 - $28,642	-325 Reduced 5.33%	5,771 $505,000
Q3 2021 Oct 13, 2021	SELL	$81.78 - $95.14 $14,393 - $16,744	-176 Reduced 2.81%	6,096 $499,000
Q2 2021 Jul 14, 2021	BUY	$85.24 - $94.15 $8,609 - $9,509	101 Added 1.64%	6,272 $572,000
Q1 2021 Apr 27, 2021	SELL	$83.5 - $98.47 $19,873 - $23,435	-238 Reduced 3.71%	6,171 $527,000
Q4 2020 Jan 21, 2021	BUY	$78.07 - $94.43 $1,014 - $1,227	13 Added 0.2%	6,409 $605,000
Q2 2020 Jul 20, 2020	BUY	$80.93 - $91.1 $971 - $1,093	12 Added 0.19%	6,396 $559,000
Q1 2020 Apr 13, 2020	SELL	$70.67 - $99.01 $16,536 - $23,168	-234 Reduced 3.54%	6,384 $526,000
Q4 2019 Jan 21, 2020	SELL	$84.35 - $95.37 $15,604 - $17,643	-185 Reduced 2.72%	6,618 $627,000
Q3 2019 Oct 24, 2019	BUY	$85.54 - $94.26 $427 - $471	5 Added 0.07%	6,803 $591,000
Q2 2019 Jul 17, 2019	BUY	$75.4 - $92.8 $5,278 - $6,496	70 Added 1.04%	6,798 $621,000
Q1 2019 Apr 11, 2019	SELL	$75.32 - $86.15 $1,129 - $1,292	-15 Reduced 0.22%	6,728 $647,000
Q4 2018 Jan 17, 2019	BUY	$73.66 - $82.02 $63,568 - $70,783	863 Added 14.68%	6,743 $579,000
Q3 2018 Oct 15, 2018	BUY	$66.94 - $77.43 $2,677 - $3,097	40 Added 0.68%	5,880 $507,000
Q2 2018 Jul 10, 2018	BUY	$64.91 - $73.36 $62,378 - $70,498	961 Added 19.7%	5,840 $441,000
Q1 2018 Apr 16, 2018	BUY	$70.39 - $84.15 $68,700 - $82,130	976 Added 25.01%	4,879 $394,000
Q4 2017 Jan 17, 2018	BUY	$72.33 - $77.64 $1,157 - $1,242	16 Added 0.41%	3,903 $328,000
Q3 2017 Oct 17, 2017	BUY	$74.14 - $77.27 $288,182 - $300,348	3,887	3,887 $334,000

Others Institutions Holding NVS

# of Institutions

1,426

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.

Account

Capital Investment Advisors, LLC Novartis Ag Transaction History